Indications
Faropenem Tablets are indicated in the treatment of the following infections:
Lower respiratory tract infections: acute bronchitis, pneumonia, pulmonary suppuration.
Ear, nose, and throat (ENT) infections: otitis externa, tympanitis, sinusitis.
Genito-urinary infections: pyelonephritis, cystitis, prostatitis, seminal gland inflammation.
Upper respiratory tract infections: pharyngitis, tonsillitis.
Skin and skin structure infections: pustular acne, folliculitis, contagious impetigo, erysipelas, lymphangitis, suppurative nail inflammation, subcutaneous abscess, hidradenitis (sweat gland inflammation), infective sebaceous cyst, chronic pyoderma, secondary infection of external wounds or surgical wounds.
Gynecological infections: adnexitis, bartholin gland inflammation.
Dosage And Administration
Upper respiratory tract infections: 150 mg t.i.d., can be increased to 200 mg t.i.d.
ENT infections: 200 mg t.i.d., can be increased to 300 mg t.i.d.
Lower respiratory tract infections: 200 mg t.i.d., can be increased to 300 mg t.i.d.
Skin and skin structure infections: 150 mg t.i.d., can be increased to 200 mg t.i.d.
Genito-urinary infections: 200 mg t.i.d., can be increased to 300 mg t.i.d.
Gynecological infections: 150 mg t.i.d., can be increased to 200 mg t.i.d.
Side Effects
Common side effects of this drug are Headache, Nausea, Vomiting, Stomach pain and Diarrhea.
Precautions And Warnings
Faropenem should be administered with caution in the following:
Patients with a past history of hypersensitivity to penicillin, cephem or carbapenem drugs.
Patients with a family history of atopy.
Patients with renal impairment. The dosage should be reduced or the interval between doses should be increased.
Geriatric patients.
Patients with poor oral intake or poor general state (since there are cases that show symptoms of vitamin K deficiency, proper monitoring should be done).
Pregnancy And Lactation
Safety regarding therapy during pregnancy has not been established. In pregnant women or expectant mothers, the medicine should be given only if the benefit of the treatment is greater than the risks involved. Faropenem is excreted in human milk. Therefore, Faropenem should be given to nursing mothers only if the benefits outweigh the risks.